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Abstract: 
Background: Intrathecal morphine for caesarean delivery provides excellent postoperative analgesia but it is commonly 
associated with nausea and vomiting. This prospective, randomized, double blind study was carried out to compare the effec-
tiveness of  a combination of  dexamethasone and ondansetron with dexamethasone alone for prevention of  postoperative 
nausea and vomiting (PONV) following intrathecal morphine injection for caesarean section. 
Methods: A total of  108 parturients aged 18-40 years for elective caesarean section were randomized into 2 groups (n=54) 
to receive either intravenous dexamethasone 8mg (Group A) or a combination of  intravenous dexamethasone 8mg and on-
dansetron 4mg (group B). The study drug for each group consisted of  0.5% hyperbaric bupivacaine and 0.2mg morphine. 
The primary outcome variables were postoperative nausea and vomiting (PONV) which were assessed for a period of  24 
hours. The patient’s vital signs were monitored and documented. 
Results: The incidence of  nausea and vomiting was significantly reduced in patients who received a combination of  dexam-
ethasone and ondansetron compared with dexamethasone alone (9.3% Vs 37%, respectively, P = 0.003). 
Conclusion: This study showed that a combination of  dexamethasone and ondansetron administered prophylactically sig-
nificantly reduced the incidence of  PONV in pregnant women on intrathecal morphine for caesarean section. 
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Introduction
Postoperative  nausea  and vomiting  (PONV)  is  a 
common  and  unpleasant  side  effects following sur-
gery. There has been a decrease in the incidence of  
PONV over the years from
60% associated with use of  potential emetogenic an-
aesthetic drugs like ether and cyclopropane to approxi-
mately 30% 1,2. However, in some high-risk patients the 
incidence is still as high as  70% 3,4. General anaesthe-
sia has long been known as causing a greater frequency 
and severity of  PONV than regional anaesthesia 4.
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Currently,  a  large  proportion  of   surgical  procedures 
are  amenable  to  regional anesthesia, thus increasing its 
popularity. Since the early 1980s, intrathecal morphine 
for caesarean section has been used to provide excellent 
postoperative analgesia following its introduction into 
central neural blockade 5, 6. Use of  opioids is associ-
ated with some major side effects such as PONV, pruri-
tus, urinary retention and respiratory depression.
The etiology of  PONV is multifactorial. Patient, an-
esthesia and surgery related factors have been identi-
fied. Various antiemetics have been used for PONV 
prophylaxis, and to date, no single drug has been found 
to be totally effective in antagonizing all receptor sites 
involved in emetic response.
Dexamethasone  and ondansetron  have  proven  to  be 
good  prophylaxis  of   PONV following orthopaedic, 
general and gynecological surgery 7  ,8,9. Although the 
efficacy of  dexamethasone as an antiemetic had been 
demonstrated in many studies, not much studies has 
been done concerning its combination with ondanset-
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ron for prevention of  PONV in parturients receiving 
intrathecal morphine for caesarean section. Hence there 
is a need to determine the efficacy of  this combina-
tion over dexamethasone alone. The findings from this 
study will serve as a local reference for other investiga-
tors in the future.
Method
The study was carried out at the Olabisi Onabanjo Uni-
versity Teaching Hospital, Sagamu, Nigeria following 
approval by the scientific and ethical committee of  the 
hospital. The study was carried out on pregnant wom-
en, aged 18-40 years, ASA I or II singleton pregnancy at 
term undergoing elective caesarean section under spinal 
anaesthesia using a combination of  morphine and bupi-
vacaine. Exclusion criteria were patients known to have 
history of  motion sickness, hypersensitivity to dexam-
ethasone, ondansetron, morphine or bupivacaine, preg-
nancy induced hypertension (PIH) and multiple preg-
nancy. Others were glucose  intolerance  or  gestational 
diabetes  patients  with  established  gastrointestinal 
diseases, patients who had taken opioids and antiemet-
ics medications within the last 24 hours, and patients 
with contraindications to spinal anaesthesia. The sam-
ple size formula for the comparison of  two proportions 
was used. The power of  the study was 90%, the α error 
= 0.05, and the expected  incidence of  PONV in the 
control group (P2) was 0.44 from previous study. Ap-
proximate sample size per group was 52 and increased 
by 10% to provide for attrition making a total of  58 pa-
tients in each group. A written informed consent from 
each patient was obtained.
The study was a double blinded, randomized, prospec-
tive clinical trial in which both the patients and the at-
tending anaesthetists were blinded to the study drugs. 
Patients were randomized to either dexamethasone 
alone (Group A) or a combination of  dexamethasone 
and ondansetron (Group B) using the table of  simple 
random numbers. Monitors were applied on the pa-
tients and baseline pulse rate, blood pressure, respira-
tory rate, oxygen saturation were taken and recorded. 
The blood pressure was measured with non-invasive 
automated machine (OMRON) while the oxygen satu-
ration, pulse rate, and respiratory rate, were taken with 
NONIN comprehensive monitor. An intravenous ac-
cess was established with either 16G or 18G cannula 
in a non-dominant forearm vein and the patient was 
preloaded with 5O0-1000 mL of  Ringer’s lactate solu-
tion over 20-30minutes before instituting the spinal an-
aesthesia.
The  study drugs were  dexamethasone,  manufac-
tured  by  Wuhan  Pharmaceutical Group   Company 
Limited,China,with   NAFDAC  Registration   Number 
04-6504, and NAFDAC Registration Number A4-0121. 
Dexamethasone 8mg, and a combination of  dexame-
thasone 8mg and ondansetron 4mg, respectively, were 
drawn into identical syringes and diluted with sterile 
water to achieve a volume of  5ml by a senior resident 
anaesthetist   who   was   not   an   investigator.   The 
syringe   containing dexamethasone 8mg was labelled 
group A, while that containing a combination of  dex-
amethasone 8mg and ondansetron  4mg was  labelled 
group B.  These freshly prepared study drugs were 
handed over to the attending anaesthetist who was part 
of  the investigation to administer to the patients (al-
ready randomized into group A and group B) before 
instituting spinal anaesthesia.
These prepared study drugs were administered intrave-
nously by the attending anaesthetist  before  instituting 
the  spinal  block.  Paturients  were  positioned  sitting; 
skin preparation and draping were under aseptic condi-
tion. After locating L2 – 3 or L3 – L4 intervertebral 
space, the skin and interspinous ligaments were infil-
trated with 2ml of  2% plain Lidocaine using 21G hy-
podermic needle. Subarachnoid block was established 
with a single bolus injection of  a combination of  2.0 
- 2.5ml of  0.5% hyperbaric bupivacaine (Astrazeneca) 
and 0.1ml of  0.2mg of  preservative free morphine us-
ing 25G Whitacre spinal needle. After instituting the 
block, the patient was returned to the supine position 
with the head supported on a pillow with a left lateral 
tilt for uterine displacement and a slight head- up tilt to 
limit cephalad spread of  the spinal agent. The vital signs 
(pulse rate, blood pressure, oxygen saturation and respi-
ratory rate) were recorded every 2 minutes for the first 
20 minutes and then every 5 minutes thereafter. Der-
matomal sensory level was determined with the use of  
ice cubes and block up to T6 was considered adequate 
for caesarean section. Supplemental oxygen at 3Litres/
min via nasal prongs was administered during the sur-
gery and discontinued after delivery of  the baby.
Nausea was defined as an unpleasant feeling associat-
ed with awareness of  an urge to vomit. Vomiting was 
defined as the forceful expulsion of  gastric contents 
from the mouth. Assessment of  nausea and vomiting 
was done hourly for the first 4 hours and then 4 hourly 
for the next 20 hours. Nausea and vomiting occurring 
within the first 4 hours of  surgery was considered early 
PONV while that occurring between 5-24 hours was 
considered as delayed or late PONV. For patients who 
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had any episode of  vomiting, a rescue antiemetic on-
dansetron 4mg intravenous bolus was given.
Statistical analysis was carried out using statistical soft-
ware package SPSS version 15.0. Descriptive statistics 
of  means and standard deviations were used for quanti-
tative variables. T-test and chi-squared2) statistics were 
used as appropriate. P-value < 0.05 was considered to 
be statistically significant.
Results
A total of  108 parturients, 54 in each group were stud-
ied out of  the 116 recruited for this study. Eight pa-
tients were excluded from the study due to inadequate 
intraoperative analgesia and had the subarachnoid block 
(SAB) converted to general anaesthesia.The two groups 
were similar with respect to demographic characteris-
tics as shown in Table 1.
 For the patients’ ASA status, 19 patients (35.2%) were 
ASA 1 and 35 patients(64.8%) were ASA ІІ in the dex-
amethasone group while 38 patients(71.7%) and 15 
patients(28.3%) were ASA І and ІІ respectively,in the 
dexamethasone and ondansetron group with a statisti-
cal significant difference(P<0.01). The mean duration 
of  surgery was 60 minutes.
Table 2 shows mean baseline pulse rate, systolic blood 
pressure, diastolic blood pressure, respiratory rate and 
oxygen saturation for dexamethasone group(group A) 
and dexamethasone and ondansetron group(group B), 
with no significant statistical difference between the 
two study groups, P > 0.05. 
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Table 1: Demographic Data 
                                             Mean ± SD 
 
Characteristics    Group A (n=54)         Group B(n=54)               T-value             P-value 
                              Dexamethasone      Dexamethasone +  
                                                                 Ondansetron 
 
Age(years)        31.80 ± 5.25           30.85 ± 4.85                 1.02              0.31 
Weight(kg)       68.97 ± 19.71         73.65 ± 13.95              1.42              0.16 
Height(m)         1.64 ± 0.07             1.63 ± 0.06                   0.14              0.89 
BMI(kg/m2)       28.26 ± 4.17          28.4 ± 4.29                   0.19              0.85 
                      455
Intraoperatively, oxygen saturation was above 98% in 
the two study groups, though all patients were routinely 
given oxygen till delivery of  the baby. The trend of  oxy-
gen saturation was slightly higher in the dexamethasone 
and ondansetron group(group B). There were no signif-
icant changes in the intraoperative mean respiratory rate 
between the two groups, and also, there was no record-
ed episode of  respiratory depression in any parturient. 
The intraoperative mean arterial pulse rates were similar 
in both study groups with no significant changes. There 
was no episode of  bradycardia in any parturient. The 
intraoperative mean systolic blood pressure and mean 
diastolic blood pressure showed similar trend in the two 
groups, respectively. Although, 26 patients had hypo-
tension overall(16 patients in the dexamethasone group 
and 10 patients in the dexamethasone and ondansetron 
group), 19 patients required treatment with intravenous 
ephedrine 3mg boluses to correct hypotension.
Table 3 shows that the frequency of  emetic symptoms 
was significantly higher in the dexamethasone group 
compared with the dexamethasone and ondansetron 
group (P < 0.05). All the emetic symptoms (nausea and 
vomiting) occurred early (0-4hours). Ten out of  the 14 
patients that vomited were given a rescue antiemetic on-
dansetron 4mg intravenous bolus.
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Table 2: Baseline Vital Signs 
                                        Mean ± SD 
 
Characteristics         Group A (n=54)               Group B(n=54)       T-value        P-value 
                                    Dexamethasone        Dexamethasone +  
                                                                           Ondansetron 
 
Respiratory Rate      22.89 ± 2.55                 22.60 ± 2.33               0.60              0.55 
(cycle/min) 
SaO2 (%)                     98.26 ± 0.76                 98.19 ± 0.68               0.51               0.61 
Pulse Rate/min         93.74 ± 13.63               92.38 ± 10.16            0.59               0.56 
Systolic Blood            129.37 ± 14.30            125.58 ± 9.72            1.60               0.11 
Pressure(mmHg) 
Diastolic Blood           82.87 ± 9.50               79.49 ± 9.14               1.86               0.64 
Pressure(mmHg) 




Nausea and vomiting are among the most distressing 
symptoms in the postoperative period. Huang et al 10 
had demonstrated a reduced incidence in PONV with 
prophylactic dexamethasone compared to placebo. In-
travenous ondansetron 4mg has also been shown to sig-
nificantly reduce the incidence of  nausea and vomiting 
in pregnant women undergoing caesarean section under 
spinal analgesia 7,11 . The results obtained from this 
study showed that the incidence of  nausea and vom-
iting was significantly reduced with a combination of  
dexamethasone  and  ondansetron  compared  to  dex-
amethasone  alone  (9.3%  and  37% respectively, P = 
0.003). This result correlates with the pattern that had 
been reported by Szarvas et  al and Lopez-Olaondo et 
al in separate studies. 
Szarvas et al in their prospective, double-blinded rand-
omized study found out that failure of  PONV prophy-
laxis in the 24 hour postoperative period occurred more 
frequently in patients who received dexamethasone alone 
(29 of  40; 73%) compared with those who received a 
combination of  dexamethasone and ondansetron(19 
of  43; 44), P=0.01. Dexamethasone is thought to have 
a late-onset antiemetic effect which might have contrib-
uted to its higher incidence of  nausea and vomiting in 
this study. All the patients who had nausea or vomiting
actually experienced them early (0-4hours). Therefore, 
in this study and in a previous study by Wang et  al 
dexamethasone could be said to be ineffective against 
early PONV. 
Better efficacy with use of  combined antiemetic proph-
ylaxis as seen in this study corroborates the findings of  
the meta-analysis of  randomized controlled trials of  
combination of  antiemetic therapy by Habib and        . 
Their study showed no significant statistical difference 
in antiemetic efficacy when one of  the 5-HT3 recep-
tor antagonists is combined with either droperidol or 
dexamethasone and that both combination regime are 
significantly more effective than 5-HT3 receptor an-
tagonist alone.
There is an association between nausea, vomiting, and 
hypotension. Emetic symptoms could be triggered by 
hypotension and hypoxaemia15 of  the brain stem due 
to spinal hypotension. Hypotension is the commonest 
immediate complication following spinal anaesthesia in 
obstetric patients. 
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Table 3: Incidence of PONV (0-24hours)                                       
 Dexamethasone 
no.(%) 
n = 54 
Dexamethasone 
+ Ondansetron       
no. (%) 
n = 54 
No PONV                                                                      34(63.0)                   49(90.7) 
 
 
Nausea Only; Early 0-4 hours                                   9(16.7)                      2(3.7) 
                         Late 5-24hours                                         _                               _ 
 
 
Vomiting or retching; Early 0-4 hours                     11(20.3)                    3(5.6) 
                                       Late 5-24 hours                          _                                _ 
                          
Chi-squared (x2) value = 11.74 
                           P-value = 0.003 
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Patra et al noted that emetic symptoms were reduced 
in patients who developed   post-spinal   hypotension 
after   being   given   100%   oxygen,   thus,   implicating 
hypoxaemia at the emetic centre as a probable causative 
factor. There were no significant changes between the 
two groups with respect to maternal pulse rate, respira-
tory rate and oxygen saturation. Ephedrine was used in 
this study as the vasopressor of  choice because it was 
readily available and on the basis that it does not appre-
ciably affect uterine blood flow unlike the pure alpha 
adrenergic agonist phenylephrine which causes increase 
in uterine artery resistance and may  reduce  placental 
blood  flow  despite  effective  treatment  of   maternal 
hypotension   .
Although  a recent study has shown that such changes 
do not appear to have any effects on healthy parturi-
ents.
None of  the patients in this study manifested any res-
piratory depression which was defined as respiratory 
rate <10 cycles/minutes probably because of  the low 
dose intrathecal morphine (0.2mg) that was used for the 
study, though previous studies20,21 had reported that 
it was unlikely to have respiratory depression with low 
dose intrathecal morphine. Commonly reported  side 
effects  of   ondansetron  are  headache,  flushing  at 
site  of   injection  and constipation. No side effects of  
ondansetron were observed during the study.
Conclusion
The study demonstrated the efficacy of  combining dex-
amethasone with ondansetron over use  of   dexametha-
sone  alone  as  antiemetic  prophylaxis  in   paturients 
receiving intrathecal morphine for caesarean delivery.
Recommendation
When   parturients   are   undergoing   caesarean   de-
livery   with   intrathecal   morphine, combination of  
antiemetics prophylaxis using dexamethasone and on-
dansetron should be considered because of  its superior 
antiemetic quality.
Limitation of  the study
Measurement of  blood levels of  the drugs used so as 
to know if  therapeutic levels were reached could not be 
done because of  lack of  facilities.
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